Overview
Dr. Akiko Chiba is an Associate Professor of Surgery at Duke University Medical Center and Associate Program Director of Duke Breast Surgery Fellowship Program. She is a breast surgical oncologist who cares for patients with breast cancer, benign breast diseases and those with an increased risk of breast cancer. Her clinical interests include young patients with breast cancer, genetic mutation carriers, and de-escalation of surgical treatment after neoadjuvant therapies. She is also studying the role of microbiome in breast cancer and how modulation of microbiome could be used to improve patient outcome.
In addition to her role at Duke Cancer Institute, Dr. Chiba serve as an advisory board member of Breast and Gyn Oncology System of Excellence with National Oncology Program Office, Veterans Health Administration. This is a national program to improve care for breast and gynecologic cancer of veterans. She is also the lead physician for National Teleoncology High Risk Breast Cancer Clinic. On the national level, she serves on the Breast Committee for Alliance for Clinical Trials in Oncology, Co-Chair of Editorial Committee for Association of Women Surgeons, and Vice-Chair of Member Engagement Committee for American Society of Breast Surgeons.
Office Hours
Current Appointments & Affiliations
Recent Publications
"Emotional intelligence in surgery: Critical skills for modern surgeons and trainees".
Journal Article Am J Surg · December 2025 Full text Link to item CiteASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.
Journal Article Ann Surg Oncol · October 15, 2025 Full text Link to item CiteSurgical Considerations for Patients With de Novo Metastatic Breast Cancer Based on Prognostic Group.
Journal Article J Surg Res · October 9, 2025 INTRODUCTION: Advances in systemic therapy for de novo metastatic breast cancer (dnMBC) led to the development of a novel staging system (IVA-D), which stratifies patients into prognostic subgroups based on tumor characteristics and metastatic extent. Over ... Full text Link to item CiteRecent Grants
A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci® SP Surgical System vs Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures
Clinical TrialPrincipal Investigator · Awarded by Intuitive Surgical, Inc. · 2023 - 2033Exploring the Relationship Between the Oral Microbiome and Fatigue in Individuals with Breast Cancer: A Longitudinal Study
FellowshipCollaborator · Awarded by National Institutes of Health · 2024 - 2026View All Grants